BIOMAT Database Logo BIOMAT Database Logo

Potentiation of warfarin action by sulphinpyrazone. 1980

R R Bailey, and J Reddy

UI MeSH Term Description Entries
D008297 Male Males
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013442 Sulfinpyrazone A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. Sulfoxyphenylpyrazolidin,Anturan,Anturane,Apo-Sulfinpyrazone,Nu-Sulfinpyrazone,Sulphinpyrazone,Apo Sulfinpyrazone,Nu Sulfinpyrazone
D014859 Warfarin An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin

Related Publications

R R Bailey, and J Reddy
Potentiation of action of warfarin by itraconazole.
September 1990, BMJ (Clinical research ed.),
R R Bailey, and J Reddy
Cimetidine potentiation of warfarin action.
January 1982, Canadian Medical Association journal,
R R Bailey, and J Reddy
Potentiation of warfarin action by miconazole oral gel.
December 1991, Australian and New Zealand journal of medicine,
R R Bailey, and J Reddy
Biphasic sulphinpyrazone-warfarin interaction.
April 1981, British medical journal (Clinical research ed.),
R R Bailey, and J Reddy
Interaction of sulphinpyrazone with warfarin.
January 1982, European journal of clinical pharmacology,
R R Bailey, and J Reddy
Potentiation by glucagon of the hypoprothrombinemic action of warfarin.
March 1970, Annals of internal medicine,
R R Bailey, and J Reddy
Potentiation of anticoagulant response to warfarin by sulphinpyrazone: a double-blind study in patients with prosthetic heart valves.
January 1982, Clinical and laboratory haematology,
R R Bailey, and J Reddy
Sulphinpyrazone and warfarin after myocardial infarction.
August 1979, British medical journal,
R R Bailey, and J Reddy
Sulphinpyrazone and warfarin after myocardial infarction.
July 1979, British medical journal,
R R Bailey, and J Reddy
Potentially serious interaction of warfarin with sulphinpyrazone.
January 1981, The Medical journal of Australia,
Copied contents to your clipboard!